Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 4Brain Neoplasms 4Astrocytoma 4Oligodendroglioma 3Gliosarcoma 3Glioma 3Central Nervous System Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Medulloblastoma 1Head and Neck Neoplasms 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Hepatocellular 1

Interventions

Filgrastim 11Temozolomide 9Peripheral Blood Stem Cell Transplantation 6Carboplatin 5Irinotecan 4sargramostim 3Oxaliplatin 3O(6)-benzylguanine 3Cyclophosphamide 3Vorinostat 2Vincristine 2Thiotepa 2Psychiatric Rehabilitation 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Cisplatin 2Carmustine 2Busulfan 2veliparib 1trioctyl phosphine oxide 1romidepsin 1ribociclib 1phenylacetic acid 1palbociclib 1olaparib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Familial ependymoma × Genetic Therapy × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡